Denise Carter - 23 Dec 2024 SCHEDULE 13D Report for Quoin Pharmaceuticals Ltd. Ordinary Shares, no par value per share (represented by American Depositary Shares) (QNRX)

Filing Manager: Denise Carter
Reporting Manager: Denise Carter
Security: Quoin Pharmaceuticals Ltd. Ordinary Shares, no par value per share (represented by American Depositary Shares)
Symbol: QNRX
Shares outstanding: 9,020,478 shares
Disclosed Ownership: 622,413 shares
Ownership: 6.9%
Form type: SCHEDULE 13D
Filing time: 02 Jan 2025, 17:20:45 UTC
Date of event: 23 Dec 2024
Next filing: 28 Jan 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Denise Carter	6.9%	622,413	622,413	0	/s/ Denise Carter	Denise Carter	0001958621